Product Information

OXYMORPHONE HCL 10 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $1.2245 per EA under NDC 10702007106. Its NADAC has been published 280 times since Jan 9, 2019.

FDA first approved this application on Jan 30, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYMORPHONE HCL 10 MG TABLET

Oxymorphone Hydrochloride
$1.2245per EA
DEA Schedule CII

Strength

10 mg/1

Manufacturer

KVK-Tech Inc.

NDC

10702007106

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/27/2025

Active Ingredients

OXYMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203601

FDA Approved

1/30/2013

TE Code

AB

On Market Since

2/11/2013

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for OXYMORPHONE HCL 10 MG TABLET has been published 280 times since Jan 9, 2019, and over the history we have for it it has declined 10.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2245 per EA
All-time high$1.5663 (Mar 13, 2019)
All-time low$0.2729 (Jul 21, 2021)
52-week high$1.2245
52-week low$1.2245
Median price$0.9700
Average price$0.9131
Largest weekly change+128.2% (Aug 27, 2025)
Weeks tracked280
Tracking sinceJan 9, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

0.0%

1Y

+128.2%

3Y

+128.2%

5Y

+183.3%

All

-10.8%

Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXYMORPHONE HCL 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 10 MG TABLET, manufactured by KVK-Tech Inc., is $1.2245 per EA (NDC 10702007106), effective May 13, 2026.

How has the price of OXYMORPHONE HCL 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYMORPHONE HCL 10 MG TABLET has declined 10.8%. It has been tracked across 280 weekly CMS publications since Jan 9, 2019.

What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 10 MG TABLET?

Since Jan 9, 2019, the NADAC for OXYMORPHONE HCL 10 MG TABLET has ranged from a low of $0.2729 (Jul 21, 2021) to a high of $1.5663 (Mar 13, 2019), with a median of $0.9700 per EA.

Are there cheaper alternatives to OXYMORPHONE HCL 10 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYMORPHONE HCL 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXYMORPHONE HCL 10 MG TABLET?

OXYMORPHONE HCL 10 MG TABLET (NDC 10702007106) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.